Robert Axtell to Biomarkers
This is a "connection" page, showing publications Robert Axtell has written about Biomarkers.
Connection Strength
0.366
-
Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL. Mult Scler Relat Disord. 2022 Jul; 63:103922.
Score: 0.160
-
ELTD1 as a biomarker for multiple sclerosis: Pre-clinical molecular-targeted studies in a mouse experimental autoimmune encephalomyelitis model. Mult Scler Relat Disord. 2021 Apr; 49:102786.
Score: 0.146
-
Current and Future Biomarkers in Multiple Sclerosis. Int J Mol Sci. 2022 May 24; 23(11).
Score: 0.040
-
Serum IL-17F does not predict poor response to IM IFNß-1a in relapsing-remitting MS. Neurology. 2012 Aug 07; 79(6):531-7.
Score: 0.020